Clinical Trial Update: Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating the combination of cemiplimab with dabrafenib and trametinib in patients with anaplastic thyroid carcinoma, with an …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Thyroid Cancer

Drugs mentioned

• Dabrafenib (Dabrafenib)
• Libtayo (cemiplimab)
• Trametinib (trametinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Anaplastic Thyroid Cancer, Thyroid Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING